As AI takes a more prominent space in our lives and workplaces, it's essential that we protect our cognitive real estate (and ...

Catarina Craveiro, a biomedical research technician from Lisbon, had been hobbled by lower back pain from scoliosis since ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Animal models had suggested that donepezil, used to stabilize dementia symptoms, may alleviate psychiatric symptoms and ...